| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |